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CASE PRESENTATION

OBJECTIVE

q HPI : 86 year-old male with mild dementia and alcoholism who
suffered a right hip fracture following a fall

§ Duloxetine-induced SIADH has been seldom reported

§ This case study emphasizes the importance of suspecting rare
adverse effects of recurrent SIADH after switching an SSRI to
duloxetine in older adults

•
•

BACKGROUND
q Hyponatremia : serum sodium < 135 mmol/L

•
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He underwent R hip repair in April 2015 and was discharged to
a rehab facility where his course was complicated by pneumonia
He developed depression and attempted suicide by hanging in
August 2015
He was transferred to a Geriatric psychiatric unit

§ PMH : TIA, alcoholism, a-fib, dementia, recurrent falls, restless leg
syndrome, GERD, h/GI bleed, IBS, mild anemia

• Symptoms: anorexia, nausea/vomiting, poor concentration,
confusion, lethargy, agitation, headache, seizures, coma

§ Medications : Ropinirole, zolpidem, thiamine, percocet, ativan,
memantine, Donepezil, Atenolol, FeSO4

• Associated with considerable morbidity and mortality
q Syndrome of inappropriate antidiuretic hormone
secretion (SIADH) 1 2
• Accounts for nearly 60% of all hyponatremias

q Drug-induced Hyponatremia 2

• Discontinuation of suspected drugs, fluid restriction, salt intake,
tolvaptan, demeclocycline, 3% normal saline (if severe)

• There is only one other case reported on recurrent hyponatremia
after substitution of citalopram with duloxetine 5
q Consideration

• Older adults started on duloxetine should be closely monitored for
hyponatremia, especially within a week of the treatment 5
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• Started on citalopram 10mg QD
• Baseline serum: Na 135 mM on admission
• The dose was increased to 30mg q daily within 1 week
• Patient reported feeling weaker and drowsy
• Serum Na 122 mM (Se Osm 258,Ur Osm 771,Urine Na 47)
• Workup for hyponatremia suggested SIADH
• Citalopram was switched to duloxetine 20mg QD
• Initiated fluid restriction
• Serum Na 129 mM (3days after citalopram was discontinued)

CONCLUSION
•

Duloxetine-induced hyponatremia is rare but can occur,
even with doses as low as 20mg/day in the elderly.

•

SNRI may induce hyponatremia in patients with SSRIinduced hyponatremia

•

Closer monitoring of serum sodium level is required
after initiating duloxetine in older adults
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Trend of serum sodium level during hospitalization
Serum Sodium mmol/L

q Management of duloxetine-induced SIADH 1,2,5

• Our patient was using the lowest dose of duloxetine (20mg QD)
(duloxetine was used for MDD at 30 to 120 mg QD in other cases)

§ P/E : unremarkable. Neurologic: AAO x 3 , mild BLE weakness
Psychiatric: (+)depressed mood, (-) suicidal ideation or plan.
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• Indications : major depressive disorders, diabetic neuropathy,
fibromyalgia, urinary stress incontinence

• Female gender, polypharmacy, lower baseline serum sodium
concentration, low body weight and old age

q Significance of our case

§ V/S : BP 122/82, HR 70, RR 18, T 98.0, Ht 5’9’’,Wt 140lb,BMI 20.7

q Duloxetine : serotonin-norepinephrine reuptake inhibitor (SNRI)

q Risk factors for duloxetine-induced SIADH

(1) Old age (2) low body weight (3) low baseline serum sodium level

• We should be aware of duloxetine-induced SIADH while treating
older adults with lower duloxetine dosages because serious
hyponatremia may be mistaken for worsening of depression

q Clinical course during the hospitalization

Common causes
Rare causes
Thiazide diuretics
ACE inhibitor
SSRI
Amlodipine
TCA
Immunoglobulin (IV)
MAO inhibitor
Bactrim, Ciprofloxacin
Typical Antipsychotics
Amiodarone
Antiepileptic drugs
Proton pump inhibitors
Anticancer agents
Duloxetine
Venlafaxine
Bupropion
• Characterized by an excess of ADH, most frequently caused by
SIADH or effective circulating volume depletion
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q Risk factors for duloxetine-induced hyponatremia

§ Labs (on admission) : Hb 10.6, TSH 2.34, B12 596, folate 21
CMP : Na 135 K 3.8 BUN 16 Cr. 0.5

• Euvolemic, Serum osm < 275, Urine osm > 100, Urine Na > 30

• SSRIs are well recognized for causing SIADH and hyponatremia

DISCUSSION
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q For additional information, please contact:
Dae Hyoun “David“ Jeong, MD
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